Skip to main content
padlock icon - secure page this page is secure

Advances in Irrigated Tip Catheter Technology for Treatment of Cardiac Arrhythmias

Buy Article:

$63.00 + tax (Refund Policy)

Radiofrequency catheter ablation without active cooling of the catheter tip is associated with significantly increased risk of thrombus formation and thromboembolism, especially when multiple and high-energy deliveries are considered. Therefore, irrigation of the distal electrode has become obligatory for catheter ablation of complex cardiac arrhythmias. The advancement in the cooling catheter technology is aimed to further reduce the risk of steam pop as well as coagulum formation on both electrode and tissue, and to maximize energy transfer to the tissue. Whether novel catheter designs will translate into better success rates of catheter ablation and lower risk of complications remains to be evaluated by upcoming studies. In future, a combination with novel sensors that enable online monitoring of lesion creation is expected. Such technology should allow optimization of radiofrequency delivery without risk of deep tissue overheating and steam pop creation. Recent patents in the field of irrigated ablation catheter focus mainly on novel porous materials that would enable diffuse irrigation around the catheter tip and alternative layout of irrigation holes. Additionally, some patents deal with combination of irrigation fluid tubing and different sensors located within the catheter tip.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Atrial fibrillation; catheter ablation; cool flow; irrigated tip technology; radiofrequency current

Document Type: Research Article

Publication date: 01 April 2013

More about this publication?
  • Recent Patents on Cardiovascular Drug Discovery publishes review articles on recent patents in the field of cardiovascular drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on cardiovascular drug discovery is also included in the journal. The journal is essential reading for all researchers involved in cardiovascular drug design and discovery.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more